Trial NCT04988308

View at ClinicalTrials.gov 
Org. Study IDs: CR109063
Secondary IDs: 2020-002607-19 77474462HDS2001

Last trial update was posted on 2023-11-13

MeSH Interventions

Adalimumab

MeSH Conditions

Hidradenitis Hidradenitis Suppurativa

Other Conditions


Stopping Reasons

Study has been prematurely terminated as the Interim Analysis 1 efficacy results met the prespecified futility criteria related to the primary endpoint.

Limitations And Caveats

As per change in planned analysis, Part 2 and some secondary efficacy analysis of Part 1 in this study was not conducted due to early termination because interim analysis 1 efficacy results met the prespecified futility criteria related to the primary endpoint. Hence, data for Part 2 and some secondary efficacy outcome measures (Parts 1 and 2) were not collected in this results summary.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID